Incheon – November 03, 2026 -- Samsung Biologics (KRX: 207940.KS) has earned an ESG Risk Rating score of 9.0 from Morningstar Sustainalytics, placing the contract development and manufacturing organization (CDMO) among the top 0.5% of companies assessed in the pharmaceuticals industry.

NEW YORK – September 24, 2026 -- XDI (Cross Dependency Initiative) and Veridion have launched a partnership that merges engineering-based climate risk modeling with corporate site intelligence covering roughly 600 million companies and more than two billion buildings worldwide.